India's pharmaceutical manufacturing industry is entering a delicate phase in its development. As uncertainty grows over its ...
Belgo-Dutch immunology specialist argenx announced that it will discontinue the Phase III UNITY study of efgartigimod ...
When the World Health Organization (WHO) updates its Model List of Essential Medicines (EML), it gives governments a ...
Belgian life sciences company SpectaCell has launched with 6 million euros ($6.7 million) in seed financing to develop a cell ...
The US Food and Drug Administration (FDA) has approved oche’s Tecentriq atezolizumab) and Tecentriq Hybreza (atezolizumab and ...
USA-based companies Viatris and Pacira BioSciences have entered into a definitive agreement under which Viatris has agreed to ...
US pharma major Bristol Myers Squibb said its Phase III EXCALIBER-RRMM trial met its progression-free survival (PFS) endpoint ...
Japan’s Ono Pharmaceutical today announced that it has entered into an exclusive license agreement with US biopharma Biohaven for the development and commercialization of Biohaven’s IgG degrader ...
Privately-held US biopharma Cerevance said its Phase III ARISE trial of once-daily oral solengepras met its primary endpoint ...
Japanese drugmaker Shionogi and Ceolia Pharma have entered into an agreement regarding the transfer of the marketing ...
Biohub, the nonprofit research institute combining AI and biology, has joined the US Department of Energy (DOE), the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results